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Abstract
Achalasia is an esophageal motility disorder character-
ized by failure of lower esophageal sphincter (LES) 
relaxation and is rare in children. The most common 
symptoms are vomiting, dysphagia, regurgitation, and 
weight loss. Definitive diagnosis is made with barium 
swallow study and esophageal manometry. In adults, 
endoscopic biopsy is recommended to exclude malig-
nancy however; it is not as often indicated in children. 
Medical management often fails resulting in recurrent 
symptoms and the ultimate definitive treatment is sur-
gical. Laparoscopic Heller myotomy with or without an 
anti-reflux procedure is the treatment of choice and 
has become standard of care for children with achala-
sia. Peroral endoscopic myotomy is a novel therapy uti-
lized with increasing frequency for achalasia treatment 
in adults. More experience is needed to determine the 
safety, efficacy, and feasibility of peroral endoscopic 
myotomy in children. 
© 2014 Baishideng Publishing Group Co., Limited. All rights 
reserved.
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Core tip: Achalasia is a neurodegenerative disorder 
of the lower esophageal sphincter which occurs less 
commonly in children compared to adults and patients 
present with progressive dysphagia, vomiting, and 
weight loss. Medical therapy including botulinum toxin 
injection and endoscopic dilatation have been associat-
ed with only transient relief of dysphagia symptoms as 
is also seen in adults. While current evidence also sug-
gests that the surgical approach of laparoscopic Heller 
myotomy provides lasting benefits for children with 
achalasia, future prospective evaluation will need to be 
conducted to ascertain whether peroral endoscopic my-
otomy is safe and equally effective in children. 
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INTRODUCTION
Achalasia is a rare esophageal neurodegenerative dis-
order in the pediatric population. The disease is even 
more infrequent in children less than 5 years of  age. The 
incidence of  achalasia in childhood is 0.11/100000 chil-
dren annually[1,2]. Overall, less than 5% of  patients with 
symptoms present under the age of  15[3]. The disease 
is more prevalent in males and is most commonly idio-
pathic. Achalasia has been associated with Trisomy 21, 
congenital hypoventilation syndrome, glucocorticoid in-
sufficiency, eosinophilic esophagitis, familial dysautono-
mia, Chagas’ disease, and achalasia, alacrima, and ACTH 
insensitivity (AAA) syndrome[3].
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leads to the sequelae of  achalasia. The pathophysiologic 
basis of  achalasia is characterized by the degeneration of  
the inhibitory myenteric plexus that innervates the lower 
esophageal sphincter (LES) and esophageal body[4]. This 
leads to an imbalance in the inhibitory and excitatory 
neurons resulting in the failure of  the LES to relax with 
swallowing, absence of  peristalsis of  the esophageal 
body, and increased LES resting pressures[5]. Goldblum 
et al[6] found a depletion or absence of  myenteric gan-
glion cells, destruction of  myenteric nerves, and chronic 
myenteric inflammation in 42 esophageal specimens. It 
is supposed that abnormalities in the parasympathetic 
innervation of  the esophagus result in the esophageal 
dysmotility seen in achalasia; however the precise etiol-
ogy of  this abnormality is unclear[7]. 
Children usually present with progressive dysphagia, 
vomiting, and weight loss. Younger children and infants 
may also present atypically with recurrent pneumonia, 
nocturnal cough, aspiration, hoarseness, and feeding dif-
ficulties[3,8]. Achalasia in children is often misdiagnosed 
as gastroesophageal reflux disease (GERD). Children 
frequently present with failure to thrive, eating disorders, 
eosinophilic esophagitis, or asthma, which then leads 
to a delay in diagnosis for as long as 6-10 years[3]. Up to 
50% of  children are treated with antacids or prokinetics 
before the diagnosis of  achalasia is identified[2]. 
DIAGNOSIS
Achalasia is diagnosed with a barium swallow study and 
may be confirmed with esophageal manometry. Barium 
swallow studies classically demonstrate a dilated esopha-
gus with “bird’s-beak” like tapering of  the distal esopha-
gus. Often, since there is a significant delay in diagnosis 
of  achalasia in children, the esophagram study alone is 
diagnostic. Elevated resting LES pressure, absent or low-
amplitude peristalsis, or non-relaxing LES upon swal-
lowing are diagnostic findings on esophageal manometry 
in children with achalasia[1,2]. However, absence of  these 
findings does not rule out the diagnosis of  achalasia 
since LES function in children is heterogeneous. Partial 
relaxations are common and normal relaxations may also 
be present on manometry according to Morea et al[8]. 
Upper endoscopy and biopsy is reasonable to rule out 
esophagitis, Trypanosoma cruzi, malignancy, and other 
secondary causes of  achalasia[1,4,5]. Our institutional pro-
tocol for work up consists of  a barium swallow study, 
upper endoscopy, and endoscopic biopsy. 
The various methods of  treatment of  achalasia in-
volve reduction of  LES pressure in order to facilitate 
esophageal emptying by: injection of  botulinum toxin, 
oral administration of  calcium channel blockers (Nife-
dipine), pneumatic dilatation, or esophageal myotomy 
(Heller) with or without an anti-reflux procedure. 
MEDICAL THERAPY
Nifedipine, a calcium channel blocker, inhibits the trans 
membrane calcium influx in cardiac and smooth muscle 
and has been primarily used to treat achalasia in adults[5]. 
In children, the use of  nifedipine has not been well stud-
ied. Maksimak et al[9] reported 4 children treated with 
nifedipine before meals who reported relief  of  symp-
toms likely related to a decrease in resting LES pressure. 
In either children or adults, nifedipine is not a definitive 
therapy and should only rarely be used as a bridge to re-
lieve symptoms until pneumatic dilatation, Botox injec-
tion or myotomy can be performed[5,10]. 
ENDOSCOPIC THERAPY
Botulinum toxin injected into the LES acts on the excit-
atory terminal nerve endings of  the myoneural junctions 
preventing acetylcholine release. Acetylcholine releasing 
neurons function in influencing the basal muscle tone[1]. 
Injection of  botulinum toxin into the LES can be both 
diagnostic and therapeutic. Optimal dosing and injec-
tion frequency of  botulinum toxin to relieve achalasia 
symptoms in children has not been well defined. After 
botulinum injection, the mean duration of  symptom 
relief  is 4 months, often requiring multiple treatments 
within a year[11]. In addition, botulinum toxin injection 
only provides permanent relief  in 10%-40% of  cases in 
adult patients[12] thus, will often require definitive surgical 
management. 
PNEUMATIC DILATATION
Pneumatic dilatation or dilation of  the functionally ob-
structed esophagus has been used in children. Recom-
mended balloon sizes in children > 8 years is 35 mm[13,14]. 
Multiple dilatations are often required to achieve suc-
cessful relief  of  symptoms although initial response pre-
dicts the success or failure of  subsequent dilatations[15]. 
Hamza et al[14] reported a 90% success rate in children 
treated with multiple pneumatic dilations. The advan-
tages of  balloon dilatation include shorter length of  stay, 
quicker recovery time, and decreased cost[13]. Pneumatic 
dilatation can be complicated by substernal pain, pro-
longed epigastric pain, esophageal perforation, aspiration 
pneumonia, and GERD[13,16-19]. Multiple studies suggest 
that in older children, pneumatic dilation is effective and 
safe initial treatment for achalasia and may spare children 
with achalasia an operation[13,14,20]. There are no long-
term follow up studies in children to document success 
rates of  pneumatic dilatation for achalasia. For adult 
patients, Eckardt et al[21] reported recurrence rates in as 
high as 60% in patients who underwent a single pneu-
matic dilation. Recurrent symptoms in children following 
multiple dilatations may require surgical myotomy[17,18,22].
SURGICAL
Despite multiple treatments for achalasia, surgery is 
the most definitive and successful treatment of  choice. 
Laparoscopic Heller myotomy (LHM) involves making 
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a longitudinal incision in the muscle of  the esophagus 
approximately 5 cm above the esophagogastric junction 
and extending 2-3 cm onto the cardia of  the stomach. 
Laparoscopic Heller myotomy in children as in adults is 
the surgical treatment of  choice[20,23-26]. 
Over the last 8 years at our institution, 24 patients 
were diagnosed with achalasia that subsequently under-
went surgical treatment. Forty-six percent of  the patients 
were male with a mean age of  11 (5-18 years). (Table 
1) In this patient population, associated comorbidities 
included: mixed connective tissue disease scleroderma 
(1); Down’s syndrome (1); inflammatory bowel disease 
(1); Sjogren’s syndrome; and Pott’s disease (1). The 
most common presenting symptoms were dysphagia 
(83%), emesis (58%), weight loss (46%), and chest pain 
(42%). Average weight loss was 9.9 kg requiring supple-
mental nutrition. Mean duration of  symptoms prior to 
surgical treatment was 2.8 years, which was consistent 
with multiple studies[16,26-31]. Upper endoscopy in our 
patients commonly showed a dilated esophagus with 
retained food products. Approximately one-third of  
our patients had an abnormal biopsy. Four patients had 
acute esophagitis one of  which was treated for Candida. 
Esophageal manometry was done in only 38% of  our 
patients secondary to inability to tolerate the procedure. 
Only 2 patients (8%) who underwent myotomy were 
treated with nifedipine with only temporary relief  of  
symptoms. Four underwent pneumatic dilatation (17%). 
In 1 patient, pneumatic dilatation was complicated by 
esophageal perforation requiring video-assisted thoraco-
scopic surgery (VATS) drainage and prolonged hospital 
stay. This patient subsequently underwent a laparoscopic 
Heller myotomy (LHM) and Dor fundoplication with 
resolution of  symptoms of  achalasia at 3 month follow 
up. Most of  our patients (88%) underwent laparoscopic 
Heller myotomy with a Dor or Thal fundoplication. Av-
erage age at the time of  surgical treatment was 12.9 years 
of  age (5-18) (Table 2). Average operating time was 124 
min.
In our series, we had only 2 intraoperative mucosal 
perforations, which were repaired primarily laparo-
scopically in children that had had LHM without fun-
doplication. Two children who had LHM with Thal 
fundoplication developed recurrent dysphagia requiring 
pneumatic dilations several months later. One patient 
who underwent a LHM and Dor fundoplication required 
a laparoscopic redo LHM and Dor for recurrent dyspha-
gia. All of  our patients receive a barium swallow study 
and a clear liquid diet on the first postoperative day. We 
have had no incidence of  leak on the esophagram in our 
patients postoperatively or delayed perforations. We rou-
tinely discharge our patients on postoperative day 2 and 
our average length of  stay is 2.6 d. Eight percent of  our 
patients had recurrent symptoms of  dysphagia postoper-
atively. One patient required revision of  the initial opera-
tion 10 mo after the first operation (Table 3). There was 
a significant improvement in symptoms after the second 
procedure. As seen in other centers, most patients with 
recurrent dysphagia after surgical treatment for achalasia 
undergo balloon dilatation with improvement in their 
symptoms (Table 3).
The laparoscopic approach is superior to the open 
approach secondary to the well-recognized benefits in-
cluding minimal pain, better cosmesis, shorter hospital 
stay, and faster return to normal activity for the child and 
parent/guardian[26]. Common causes of  surgical failure 
are GERD and recurrent dysphagia. A partial fundopli-
cation is commonly used to prevent GERD in patients 
following Heller myotomy. In a randomized controlled 
trial, Rebecchi et al[32] determined that laparoscopic Dor 
fundoplication after a LHM was superior to Nissen 
fundoplication because the recurrence rate of  dyspha-
gia was significantly higher in patients who received a 
Nissen fundoplication in their adult patients. There is 
some controversy as to whether an anti-reflux procedure 
should be performed in children at the time of  LHM. 
Corda et al[24] concluded that an anti-reflux procedure is 
not required with a LHM for the prevention of  GERD. 
Other studies have shown benefits and it is our practice 
to perform LHM and partial fundoplication[27,28,31,33].
The two primary complications of  surgical man-
agement of  achalasia are esophageal perforation and 
recurrent dysphagia. In our experience and review of  
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Table 1  Patient demographics
Mean
Gender
   Female 13 54%
   Male 11 46%
Age of diagnosis 11 5-18
Duration of symptoms 2.8 years 1-11 years
Presenting symptoms n Percentage
   Dysphagia 20 83%
   Emesis 14 58%
   Weight loss 11 46%
   Chest pain 10 42%
   Regurgitation   4 17%
   Odynophagia   2   8%
Table 2  Surgical approach
Mean
Age at surgery 12.9 5-8
OR time 124 min 45-213 min
LOS 2.7 d 1-6 d
Follow up 3.5 mo 1-12 mo
n Percentage
LHM   3 12.50%
LHM + TF   2   8.30%
LHM + DF 19 79.20%
LOS: Length of stay; LHM: Laparoscopic Heller myotomy; TF: Thal 
fundoplication; DF: Dor fundoplication. 
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nique in the treatment of  achalasia. POEM is one of  
few procedures utilizing natural orifice transluminal en-
doscopic surgery (NOTES) routinely in adults. POEM is 
an endoscopic procedure that directly treats the diseased 
tissue[23]. Pasricha et al[34] first described a submucosal en-
doscopic esophageal myotomy in animal studies for the 
treatment of  achalasia. Inoue et al[35] coined the term per-
oral endoscopic myotomy and was the first to perform 
the procedure in 17 adult patients. Multiple studies have 
concluded that short-term outcomes of  this procedure 
were safe[35-38]. 
Not all patients are suitable candidates for POEM. 
Contraindications include severe pulmonary disease, co-
agulation disorders, prior esophageal mucosal resection, 
or any prior therapy that has compromised the integrity 
of  the esophageal mucosa[37]. POEM is performed utiliz-
ing flexible endoscopy, mucosal incision and dissection 
of  a submucosal tunnel distally in the esophageal wall to 
approach the esophagogastric junction. A 2-3 cm longi-
tudinal incision in the inner circular muscle approximate-
ly 4 cm from the LES, will produce similar results to 
the literature, there was 0%-26% recurrence rate of  
dysphagia after LHM with or without an anti-reflux 
procedure (Table 3)[16,24,26-30,33]. It is unclear if  recurrent 
dysphagia is secondary to the nature of  disease or failure 
of  surgical treatment. Surgeon experience may contrib-
ute to decreasing rates of  complications as suggested by 
Esposito et al[26] since their incidence of  post-operative 
dysphagia dropped from 50%[33] to 16% with further 
experience. Our incidence of  recurrent dysphagia is 8% 
compared to 11%, 16%, 25%, and 26%[29,25,26,31] in com-
parable sized series (19-31 patients). Perforation rates 
occur from 0%-15% (8% in ours) in larger series[16,24,29,31] 
but rarely require re-operation (Table 3). Accordingly, in 
smaller series and those from longer time periods in the 
past, perforation rates were higher (22%-50%) probably 
related to the establishment of  a learning curve for the 
operation[30,33].
PER ORAL ENDOSCOPIC MYOTOMY
Peroral endoscopic myotomy (POEM) is a novel tech-
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Table 3  Surgical management of pediatric achalasia




Procedure OR time 
(min)




Pastor et al[16] 40 12.4 10.7 6 OHM 186 1 perforation Sutured - 75
3 LHM 156 2 perforations Sutured -
11 LHM  + Nissen
21 dilation
Corda et al[24] 20 12 24 20 LHM 96 4 conversions OHM 3 60
(5-15) (60-160) 5 dysphagia (1-5)
1 lap LOA 
1 redo LHM 
1 redo OHM
Esposito et al[26] 31 8.4 >12 31 LHM/Dor 120 3 perforations 2 sutured 4 9-156
(5-15) 1 redo HM (3-8)
5 dysphagia 2 dilated
1 redo OHM
Tannuri et al[27] 15 12 30 15 LHM/Dor 90 2 dysphagia 1 botox 
injection
2.5 32.5
(9-17) (150-260) (1-4) (2-96)
Patti et al[28] 13 15 24 13 LHM/Dor 144  ± 35 - - 2 19
(6-17)
Lelli et al[29] 19 10 - 14 OHM - 2 dysphagia 2 dilation 8 108
(1-17) 5 OHM + Belsey (6-252)
Rothenberg et al[30]   9 12 6-24 4 THM 95 1 perforation Sutured 2 -
(5-17) 1 dysphagia Redo LHM
2 GERD Medical Rx
5 LHM/Dor 62 1 delayed perforation Lap repair 1
Askegard-
Giesmann et al[31]
26 15 - 1 LHM - 1 perforation Sutured 2.7 0-75
(4-18) 2 LHM/Dor 1 perforation/aspiration Sutured (1-4) -20
7 dysphagia
23 LHM + Toupet 3 redo LHM
3 dilation
1 GERD 1 botox
Medical Rx
Esposito et al[32]   8 6.3 > 121 LHM 6 LHM/Dor 120 3 perforations 3 sutured 4 (3-31) 6-60
(2-13) 2 LHM/Thal (90-150)
Current Study 24 12.9 > 24 3 LHM 124 2 perforations 2 sutured 2.7 4
(5-18) 2 LHM/Thal (45-213)  (1-6) (4-24)
19 LHM/Dor 2 dysphagia 2 dilations
1 redo LHM
OHM: Open Heller myotomy; LHM: Laparoscopic Heller myotomy; THM: Thoracosopic Heller myotomy; Rx: Therapy. 
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Heller myotomy[36,38]. A contrast esophagram is routinely 
obtained on the first postoperative day and the patient is 
started on a pureed diet if  esophagram is normal[36-39]. 
Ren et al[40] reported 119 cases of  achalasia treated 
with POEM, the most common postoperative complica-
tions included subcutaneous emphysema (55.5%), pneu-
mothorax (25.2%), pneumomediastinum (29.4%), pleural 
effusion (48.7%), segmental atelectasis (49.6%), pleural 
effusion (48.7%), and pneumoperitoneum (39.5%). In 
this study, 13 patients with pneumothorax were treated 
with thoracic drainage and 2 patients with pleural effu-
sion were treated with thoracentesis. The high incidence 
of  pneumothorax, pneumomediastinum, subcutaneous 
emphysema, and pneumoperitoneum was attributed 
to the use of  air insufflation during the procedure and 
subsequently this group now utilizes CO2 insufflation[23]. 
Swanström et al[36] reported pneumoperitoneum in 3 
out of  5 patients that were treated with Veress needle. 
Inoue and associates reported pneumomediastinum in 
multiple patients, however these patients did not re-
quire treatment although another patient in that series 
underwent thoracostomy drainage tube placement[39]. 
Feasibility of  POEM is highly dependent on surgeon’
s experience, duration of  symptoms, prior pneumatic 
dilatations, and endoscopic therapies[41]. Nonetheless, 
multiple studies have reported POEM provides favor-
able outcomes and is relatively safe for the treatment of  
achalasia in adults[35-37,39-43]. Long-term outcomes (> 6 
mo) for POEM in adult patients have been reported by 
Swanström et al[44] as significant in relieving dysphagia 
in 83%. Maselli et al[45] reported the first case of  POEM 
performed in a 3-year-old with achalasia complicated 
by failure to thrive. At 1-year follow up, the patient 
was asymptomatic and had an appropriate weight for 
her age[45]. Familiari et al[46] reported 3 children treated 
with POEM for achalasia. There were no postopera-
tive complications. In this study, 2 out of  3 patients had 
complete resolution of  symptoms and the third patient 
had improvement in symptoms after 1-year follow 
up[46]. Although POEM is effective, minimally invasive, 
and safe in adults, there is also more recent evidence to 
suggest that the surgical approach (laparoscopic Heller 
myotomy) is more definitive and long lasting in reliev-
ing symptoms in these patients compared to endoscopic 
dilatation or botulinum toxin injection techniques[47]. It is 
apparent that effective therapy for children with achala-
sia is needed. Marlais et al[48] reported that children with 
achalasia have a significantly lower quality of  life (QOL) 
compared to both children with inflammatory bowel 
disease and healthy children. While current evidence also 
suggests that the surgical approach provides lasting ben-
efits for children with achalasia, future prospective evalu-
ation will need to be conducted to ascertain whether 
POEM is safe and equally effective in children. For now, 
it is unclear; however pediatric surgeons are interested 
in learning this novel technique and employing its use in 
the management of  pediatric achalasia. 
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